Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114591228B details Pd-catalyzed kinetic resolution for high-purity chiral sulfoxides. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103724264A details iridium-catalyzed asymmetric hydrogenation for high-purity chiral tetrahydroisoquinoline derivatives, offering significant cost reduction and supply chain reliability.
Patent CN115490732B discloses a novel one-pot synthesis for chiral biphenyl diol selenium sulfide catalysts offering mild conditions and cost-effective manufacturing for fine chemical intermediates.
Patent CN112979701A details a novel nickel-catalyzed resolution for L-glufosinate-ammonium. Achieve >95% yield and ee value with significant cost reduction in agrochemical manufacturing.
Patent CN104926813A enables high-yield asymmetric catalysis. Delivers supply chain stability and cost advantages for pharmaceutical intermediates manufacturing globally.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Novel oxidation method for Tenofovir intermediate ensures high purity and yield. Offers significant cost reduction and supply chain reliability for API manufacturing partners globally.
Patent CN116323522B reveals a base-free ruthenium catalyst enabling stable, scalable production of optically active secondary alcohols with superior cost efficiency.
Patent CN102174006A details a novel chiral hydroxyl amide synthesis using copper acetate, offering high conversion rates for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed asymmetric borylation route for Ruxolitinib intermediates. Reduces cost, eliminates chiral columns, ensures >99% purity for API manufacturing.
Patent CN110845369B reveals a cost-effective asymmetric Mannich route for Dapoxetine intermediates, offering superior scalability and purity for API manufacturing.
Patent CN102397793A reveals efficient cinchona-squaramide catalysts for asymmetric reactions, offering scalable synthesis and superior stereoselectivity for pharma intermediates.
Patent CN107298683B reveals a high-yield asymmetric Pictet-Spengler reaction for chiral benzodiazepines, offering cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN103772213A details a room-temperature copper-catalyzed route for (2S,3S)-2-amino-octadec-1,3-diol, offering significant cost reduction and high stereoselectivity for API manufacturing.
Patent CN101962391B discloses a novel chiral phosphine catalyst offering high enantioselectivity for nitrile cyanosilylation, ensuring reliable supply chain solutions.
Patent CN105884781B details a chiral catalytic route for Tofacitinib Citrate, offering high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Patent CN112279779B details a mild copper-catalyzed asymmetric oxime etherification. Discover high-ee pharmaceutical intermediates and cost-effective manufacturing solutions.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.